GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurora Cannabis Inc (NAS:ACB) » Definitions » Short-Term Debt & Capital Lease Obligation

ACB (Aurora Cannabis) Short-Term Debt & Capital Lease Obligation : $43.4 Mil (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Aurora Cannabis Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Aurora Cannabis's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $43.4 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Aurora Cannabis's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $31.2 Mil.


Aurora Cannabis Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Aurora Cannabis's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurora Cannabis Short-Term Debt & Capital Lease Obligation Chart

Aurora Cannabis Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Mar24
Short-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 187.88 112.62 33.50 25.78 42.27

Aurora Cannabis Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.77 18.62 42.27 39.42 43.37

Aurora Cannabis Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Aurora Cannabis Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Aurora Cannabis's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Aurora Cannabis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurora Cannabis Inc (NAS:ACB) » Definitions » Short-Term Debt & Capital Lease Obligation
Traded in Other Exchanges
Address
2207 90B Street SW, Edmonton, AB, CAN, T6X 1V8
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.